{"id":13784,"date":"2023-01-17T17:05:05","date_gmt":"2023-01-17T17:05:05","guid":{"rendered":"https:\/\/www.sygnaturediscovery.com\/sygnature-discovery-finalise-lacquisition-de-sb-drug-discovery-afin-de-renforcer-davantage-ses-capacites-de-leader-sur-le-marche\/"},"modified":"2026-02-11T09:51:12","modified_gmt":"2026-02-11T09:51:12","slug":"sygnature-discovery-finalise-lacquisition-de-sb-drug-discovery-afin-de-renforcer-davantage-ses-capacites-de-leader-sur-le-marche","status":"publish","type":"post","link":"https:\/\/www.sygnaturediscovery.com\/fr\/sygnature-discovery-finalise-lacquisition-de-sb-drug-discovery-afin-de-renforcer-davantage-ses-capacites-de-leader-sur-le-marche\/","title":{"rendered":"Sygnature Discovery finalise l’acquisition de SB Drug Discovery afin de renforcer davantage ses capacit\u00e9s de leader sur le march\u00e9."},"content":{"rendered":"

Sygnature Discovery (\u00ab Sygnature \u00bb) est ravie d’annoncer l’acquisition de SB Drug Discovery, un fournisseur mondial de premier plan dans le domaine de la recherche sur la d\u00e9couverte de m\u00e9dicaments ciblant les canaux ioniques et les r\u00e9cepteurs, proposant des solutions de g\u00e9n\u00e9ration de lign\u00e9es cellulaires et de criblage de compos\u00e9s en neurosciences et dans d’autres indications th\u00e9rapeutiques.<\/span><\/strong><\/span><\/h2>\n
\"\"

Acquisition de SB Drug Discovery par Sygnature Discovery<\/p><\/div>\n

Cette transaction offrira un avantage strat\u00e9gique aux deux entreprises, permettant un d\u00e9veloppement accru de leurs activit\u00e9s et de leurs capacit\u00e9s, et s’inscrit dans le cadre du plan strat\u00e9gique de Sygnature visant \u00e0 investir continuellement dans l’expansion de ses solutions int\u00e9gr\u00e9es de pointe pour la d\u00e9couverte de m\u00e9dicaments.<\/span><\/p>\n

\u00ab Ayant travaill\u00e9 avec Sygnature Discovery lors d’une r\u00e9cente collaboration visant \u00e0 acc\u00e9der \u00e0 notre expertise en mati\u00e8re de canaux ioniques, que nous avons pr\u00e9sent\u00e9e \u00e0 la conf\u00e9rence de la Society of Neuroscience en novembre 2022, il est devenu \u00e9vident pour Sygnature que l’\u00e9tendue de nos capacit\u00e9s et de notre expertise s’\u00e9tendait bien au-del\u00e0 de l’\u00e9lectrophysiologie des canaux ioniques, \u00e0 des domaines tels que la g\u00e9n\u00e9ration de lign\u00e9es cellulaires, le criblage et l’inflammation \u00bb<\/em> , a d\u00e9clar\u00e9 le Dr Ian McPhee, directeur scientifique chez SB Drug Discovery.<\/span><\/p>\n

Commentant cette acquisition, Ian a poursuivi : \u00ab Les valeurs et les objectifs de notre entreprise correspondent parfaitement \u00e0 ceux de Sygnature, qui vise \u00e0 devenir un chef de file dans les services de d\u00e9couverte de m\u00e9dicaments, et nous sommes ravis de devenir une partie int\u00e9grante du groupe Sygnature. \u00bb<\/em><\/span><\/p>\n

SB Drug Discovery, en activit\u00e9 depuis plus de 20 ans et employant plus de 50 personnes, continuera d’op\u00e9rer depuis ses installations de haute qualit\u00e9 \u00e0 Glasgow, avec de nouveaux investissements et un d\u00e9veloppement de ses capacit\u00e9s et services pr\u00e9vus dans les mois \u00e0 venir.<\/span><\/p>\n

\u00ab Nous sommes ravis de cette avanc\u00e9e et sommes convaincus que l’acquisition de SB Drug Discovery enrichit consid\u00e9rablement l’offre de services que Sygnature Discovery peut proposer \u00e0 ses clients, dans notre ambition de devenir le partenaire leader mondial en mati\u00e8re de d\u00e9couverte de m\u00e9dicaments. SB Drug Discovery partage notre vision et compl\u00e8te parfaitement les services existants de Sygnature. Nous sommes persuad\u00e9s que cette association permettra de b\u00e2tir un partenariat solide \u00bb,<\/em> a expliqu\u00e9 le Dr Simon Hirst, PDG de Sygnature Discovery.<\/span><\/p>\n

R\u00e9unis \u00e0 Glasgow pour annoncer l’accord au personnel, Ian et Simon, accompagn\u00e9s du Dr David Dalrymple, directeur du d\u00e9veloppement commercial de SB Drug Discovery, ont pr\u00e9cis\u00e9 que les clients ne constateraient aucune interruption de service ou de performance suite \u00e0 cette transaction, et que la direction s’engageait \u00e0 travailler avec les \u00e9quipes internes pour poursuivre la croissance des deux organisations.<\/span><\/p>\n

Il s’agit de la deuxi\u00e8me acquisition de Sygnature Discovery au cours de l’ann\u00e9e \u00e9coul\u00e9e \u2013 apr\u00e8s l’investissement de Five Arrows \u00e0 l’\u00e9t\u00e9 2021 \u2013 et apr\u00e8s l’acquisition de Peak Proteins en avril 2022, et de la cinqui\u00e8me en cinq ans. Parmi les acquisitions pr\u00e9c\u00e9dentes figurent RenaSci en 2018 ainsi qu’Alderley Oncology et XenoGesis en 2020. <\/span><\/p>\n

[Fin]<\/span><\/p>\n

\u00c0 propos de Sygnature Discovery<\/strong><\/span><\/h2>\n

Sygnature Discovery<\/a> est un partenaire de d\u00e9couverte de m\u00e9dicaments int\u00e9gr\u00e9 de premier plan mondial, offrant une expertise dans un large \u00e9ventail de domaines th\u00e9rapeutiques et de classes de cibles biologiques. Bas\u00e9e \u00e0 Nottingham et disposant d’installations \u00e0 Alderley Park et Macclesfield, elle emploie plus de 600 personnes.<\/span><\/p>\n

\u00c0 propos de SB Drug Discovery<\/strong><\/span><\/h2>\n

SB Drug Discovery<\/a> est un chef de file de l’industrie en mati\u00e8re de recherche contractuelle sp\u00e9cialis\u00e9e, fournissant des donn\u00e9es essentielles au d\u00e9veloppement de nouveaux m\u00e9dicaments gr\u00e2ce \u00e0 des services de g\u00e9n\u00e9ration de lign\u00e9es cellulaires, de d\u00e9veloppement de tests et de criblage de compos\u00e9s. SB est bas\u00e9e \u00e0 Glasgow et emploie 55 personnes.<\/span><\/p>\n

\u00c0 propos de Five Arrows<\/strong><\/span><\/h2>\n

Five Arrows<\/a> est la branche de Rothschild & Co sp\u00e9cialis\u00e9e dans les actifs alternatifs et g\u00e8re 23 milliards d’euros d’actifs sous gestion, avec des bureaux \u00e0 Paris, Londres, New York, Los Angeles, San Francisco et Luxembourg. Avec plus de 9 milliards d’euros d’actifs sous gestion, l’activit\u00e9 de capital-investissement de Five Arrows se concentre sur l’investissement dans des entreprises b\u00e9n\u00e9ficiant de positions de march\u00e9 tr\u00e8s solides ; d’\u00e9quipes de direction performantes ; de mod\u00e8les \u00e9conomiques avec une forte visibilit\u00e9 sur la croissance organique des volumes et une rentabilit\u00e9 unitaire \u00e9lev\u00e9e ; et de multiples leviers op\u00e9rationnels permettant de lib\u00e9rer de la valeur latente. Les secteurs concern\u00e9s se limitent aux donn\u00e9es et aux logiciels, aux services aux entreprises s’appuyant sur la technologie et aux soins de sant\u00e9.<\/span><\/p>\n

Pour toute demande d’information des m\u00e9dias concernant l’acquisition de Sygnature Discovery, veuillez contacter :<\/strong><\/span><\/h3>\n

Paul Overton, docteur en philosophie<\/span><\/p>\n

directeur commercial<\/span><\/p>\n

D\u00e9couverte de la signature<\/span><\/p>\n

E: paul.overton@sygnaturediscovery.com<\/a><\/span><\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":13788,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"category":[790,973],"tags":[],"class_list":["post-13784","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-bioscience","category-classes-cibles"],"acf":[],"yoast_head":"\nSygnature Discovery finalise l'acquisition de SB Drug Discovery afin de renforcer davantage ses capacit\u00e9s de leader sur le march\u00e9. - Sygnature<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.sygnaturediscovery.com\/fr\/sygnature-discovery-finalise-lacquisition-de-sb-drug-discovery-afin-de-renforcer-davantage-ses-capacites-de-leader-sur-le-marche\/\" \/>\n<meta property=\"og:locale\" content=\"fr_CA\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Sygnature Discovery finalise l'acquisition de SB Drug Discovery afin de renforcer davantage ses capacit\u00e9s de leader sur le march\u00e9. - Sygnature\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.sygnaturediscovery.com\/fr\/sygnature-discovery-finalise-lacquisition-de-sb-drug-discovery-afin-de-renforcer-davantage-ses-capacites-de-leader-sur-le-marche\/\" \/>\n<meta property=\"og:site_name\" content=\"Sygnature\" \/>\n<meta property=\"article:published_time\" content=\"2023-01-17T17:05:05+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-02-11T09:51:12+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/SB-Discovery-acquisition.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"646\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"pnpd-admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"pnpd-admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimation du temps de lecture\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/sygnature-discovery-finalise-lacquisition-de-sb-drug-discovery-afin-de-renforcer-davantage-ses-capacites-de-leader-sur-le-marche\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/sygnature-discovery-finalise-lacquisition-de-sb-drug-discovery-afin-de-renforcer-davantage-ses-capacites-de-leader-sur-le-marche\\\/\"},\"author\":{\"name\":\"pnpd-admin\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#\\\/schema\\\/person\\\/9c173ed9f4225ab61ea895ac3a939448\"},\"headline\":\"Sygnature Discovery finalise l’acquisition de SB Drug Discovery afin de renforcer davantage ses capacit\u00e9s de leader sur le march\u00e9.\",\"datePublished\":\"2023-01-17T17:05:05+00:00\",\"dateModified\":\"2026-02-11T09:51:12+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/sygnature-discovery-finalise-lacquisition-de-sb-drug-discovery-afin-de-renforcer-davantage-ses-capacites-de-leader-sur-le-marche\\\/\"},\"wordCount\":860,\"publisher\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/sygnature-discovery-finalise-lacquisition-de-sb-drug-discovery-afin-de-renforcer-davantage-ses-capacites-de-leader-sur-le-marche\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/SB-Discovery-acquisition.png\",\"articleSection\":[\"Bioscience\",\"Classes cibles\"],\"inLanguage\":\"fr-CA\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/sygnature-discovery-finalise-lacquisition-de-sb-drug-discovery-afin-de-renforcer-davantage-ses-capacites-de-leader-sur-le-marche\\\/\",\"url\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/sygnature-discovery-finalise-lacquisition-de-sb-drug-discovery-afin-de-renforcer-davantage-ses-capacites-de-leader-sur-le-marche\\\/\",\"name\":\"Sygnature Discovery finalise l'acquisition de SB Drug Discovery afin de renforcer davantage ses capacit\u00e9s de leader sur le march\u00e9. - Sygnature\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/sygnature-discovery-finalise-lacquisition-de-sb-drug-discovery-afin-de-renforcer-davantage-ses-capacites-de-leader-sur-le-marche\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/sygnature-discovery-finalise-lacquisition-de-sb-drug-discovery-afin-de-renforcer-davantage-ses-capacites-de-leader-sur-le-marche\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/SB-Discovery-acquisition.png\",\"datePublished\":\"2023-01-17T17:05:05+00:00\",\"dateModified\":\"2026-02-11T09:51:12+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/sygnature-discovery-finalise-lacquisition-de-sb-drug-discovery-afin-de-renforcer-davantage-ses-capacites-de-leader-sur-le-marche\\\/#breadcrumb\"},\"inLanguage\":\"fr-CA\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/sygnature-discovery-finalise-lacquisition-de-sb-drug-discovery-afin-de-renforcer-davantage-ses-capacites-de-leader-sur-le-marche\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-CA\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/sygnature-discovery-finalise-lacquisition-de-sb-drug-discovery-afin-de-renforcer-davantage-ses-capacites-de-leader-sur-le-marche\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/SB-Discovery-acquisition.png\",\"contentUrl\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/SB-Discovery-acquisition.png\",\"width\":1024,\"height\":646},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/sygnature-discovery-finalise-lacquisition-de-sb-drug-discovery-afin-de-renforcer-davantage-ses-capacites-de-leader-sur-le-marche\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/page-daccueil\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Sygnature Discovery finalise l’acquisition de SB Drug Discovery afin de renforcer davantage ses capacit\u00e9s de leader sur le march\u00e9.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/\",\"name\":\"Sygnature Discovery\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#organization\"},\"alternateName\":\"Sygnature\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-CA\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#organization\",\"name\":\"Sygnature Discovery\",\"url\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-CA\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/Logo.svg\",\"contentUrl\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/Logo.svg\",\"width\":1,\"height\":1,\"caption\":\"Sygnature Discovery\"},\"image\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#\\\/schema\\\/person\\\/9c173ed9f4225ab61ea895ac3a939448\",\"name\":\"pnpd-admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-CA\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/052476d339a267f4be89460f64dd24ba52137529feafa9cf45d6e8b2b62cda8b?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/052476d339a267f4be89460f64dd24ba52137529feafa9cf45d6e8b2b62cda8b?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/052476d339a267f4be89460f64dd24ba52137529feafa9cf45d6e8b2b62cda8b?s=96&d=mm&r=g\",\"caption\":\"pnpd-admin\"},\"sameAs\":[\"http:\\\/\\\/www.sygnaturediscovery.com\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Sygnature Discovery finalise l'acquisition de SB Drug Discovery afin de renforcer davantage ses capacit\u00e9s de leader sur le march\u00e9. - Sygnature","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.sygnaturediscovery.com\/fr\/sygnature-discovery-finalise-lacquisition-de-sb-drug-discovery-afin-de-renforcer-davantage-ses-capacites-de-leader-sur-le-marche\/","og_locale":"fr_CA","og_type":"article","og_title":"Sygnature Discovery finalise l'acquisition de SB Drug Discovery afin de renforcer davantage ses capacit\u00e9s de leader sur le march\u00e9. - Sygnature","og_url":"https:\/\/www.sygnaturediscovery.com\/fr\/sygnature-discovery-finalise-lacquisition-de-sb-drug-discovery-afin-de-renforcer-davantage-ses-capacites-de-leader-sur-le-marche\/","og_site_name":"Sygnature","article_published_time":"2023-01-17T17:05:05+00:00","article_modified_time":"2026-02-11T09:51:12+00:00","og_image":[{"width":1024,"height":646,"url":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/SB-Discovery-acquisition.png","type":"image\/png"}],"author":"pnpd-admin","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"pnpd-admin","Estimation du temps de lecture":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/sygnature-discovery-finalise-lacquisition-de-sb-drug-discovery-afin-de-renforcer-davantage-ses-capacites-de-leader-sur-le-marche\/#article","isPartOf":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/sygnature-discovery-finalise-lacquisition-de-sb-drug-discovery-afin-de-renforcer-davantage-ses-capacites-de-leader-sur-le-marche\/"},"author":{"name":"pnpd-admin","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#\/schema\/person\/9c173ed9f4225ab61ea895ac3a939448"},"headline":"Sygnature Discovery finalise l’acquisition de SB Drug Discovery afin de renforcer davantage ses capacit\u00e9s de leader sur le march\u00e9.","datePublished":"2023-01-17T17:05:05+00:00","dateModified":"2026-02-11T09:51:12+00:00","mainEntityOfPage":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/sygnature-discovery-finalise-lacquisition-de-sb-drug-discovery-afin-de-renforcer-davantage-ses-capacites-de-leader-sur-le-marche\/"},"wordCount":860,"publisher":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#organization"},"image":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/sygnature-discovery-finalise-lacquisition-de-sb-drug-discovery-afin-de-renforcer-davantage-ses-capacites-de-leader-sur-le-marche\/#primaryimage"},"thumbnailUrl":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/SB-Discovery-acquisition.png","articleSection":["Bioscience","Classes cibles"],"inLanguage":"fr-CA"},{"@type":"WebPage","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/sygnature-discovery-finalise-lacquisition-de-sb-drug-discovery-afin-de-renforcer-davantage-ses-capacites-de-leader-sur-le-marche\/","url":"https:\/\/www.sygnaturediscovery.com\/fr\/sygnature-discovery-finalise-lacquisition-de-sb-drug-discovery-afin-de-renforcer-davantage-ses-capacites-de-leader-sur-le-marche\/","name":"Sygnature Discovery finalise l'acquisition de SB Drug Discovery afin de renforcer davantage ses capacit\u00e9s de leader sur le march\u00e9. - Sygnature","isPartOf":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/sygnature-discovery-finalise-lacquisition-de-sb-drug-discovery-afin-de-renforcer-davantage-ses-capacites-de-leader-sur-le-marche\/#primaryimage"},"image":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/sygnature-discovery-finalise-lacquisition-de-sb-drug-discovery-afin-de-renforcer-davantage-ses-capacites-de-leader-sur-le-marche\/#primaryimage"},"thumbnailUrl":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/SB-Discovery-acquisition.png","datePublished":"2023-01-17T17:05:05+00:00","dateModified":"2026-02-11T09:51:12+00:00","breadcrumb":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/sygnature-discovery-finalise-lacquisition-de-sb-drug-discovery-afin-de-renforcer-davantage-ses-capacites-de-leader-sur-le-marche\/#breadcrumb"},"inLanguage":"fr-CA","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.sygnaturediscovery.com\/fr\/sygnature-discovery-finalise-lacquisition-de-sb-drug-discovery-afin-de-renforcer-davantage-ses-capacites-de-leader-sur-le-marche\/"]}]},{"@type":"ImageObject","inLanguage":"fr-CA","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/sygnature-discovery-finalise-lacquisition-de-sb-drug-discovery-afin-de-renforcer-davantage-ses-capacites-de-leader-sur-le-marche\/#primaryimage","url":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/SB-Discovery-acquisition.png","contentUrl":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/SB-Discovery-acquisition.png","width":1024,"height":646},{"@type":"BreadcrumbList","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/sygnature-discovery-finalise-lacquisition-de-sb-drug-discovery-afin-de-renforcer-davantage-ses-capacites-de-leader-sur-le-marche\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.sygnaturediscovery.com\/fr\/page-daccueil\/"},{"@type":"ListItem","position":2,"name":"Sygnature Discovery finalise l’acquisition de SB Drug Discovery afin de renforcer davantage ses capacit\u00e9s de leader sur le march\u00e9."}]},{"@type":"WebSite","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#website","url":"https:\/\/www.sygnaturediscovery.com\/fr\/","name":"Sygnature Discovery","description":"","publisher":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#organization"},"alternateName":"Sygnature","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.sygnaturediscovery.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-CA"},{"@type":"Organization","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#organization","name":"Sygnature Discovery","url":"https:\/\/www.sygnaturediscovery.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-CA","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/Logo.svg","contentUrl":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/Logo.svg","width":1,"height":1,"caption":"Sygnature Discovery"},"image":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#\/schema\/person\/9c173ed9f4225ab61ea895ac3a939448","name":"pnpd-admin","image":{"@type":"ImageObject","inLanguage":"fr-CA","@id":"https:\/\/secure.gravatar.com\/avatar\/052476d339a267f4be89460f64dd24ba52137529feafa9cf45d6e8b2b62cda8b?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/052476d339a267f4be89460f64dd24ba52137529feafa9cf45d6e8b2b62cda8b?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/052476d339a267f4be89460f64dd24ba52137529feafa9cf45d6e8b2b62cda8b?s=96&d=mm&r=g","caption":"pnpd-admin"},"sameAs":["http:\/\/www.sygnaturediscovery.com"]}]}},"_links":{"self":[{"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/posts\/13784","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/comments?post=13784"}],"version-history":[{"count":0,"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/posts\/13784\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/media\/13788"}],"wp:attachment":[{"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/media?parent=13784"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/category?post=13784"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/tags?post=13784"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}